Nuclear polyhedrosis virus, Autographa californica
Nuclear polyhedrosis virus, Autographa californica
规格:
货期:
编号:TS178084
品牌:Testobio
| 产品名称： | Nuclear polyhedrosis virus, Autographa californica |
|---|---|
| 商品货号： | TS178084 |
| Classification： | Baculovirus |
| Deposited As： | Nuclear pollyhedrosis virus, Autographa californica (Recombinant) |
| Agent： | Nuclear polyhedrosis virus, Autographa californica |
| Strain： | AcCC1 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Nuclear polyhedrosis virus, Autographa californica recombinant with human alpha-galactosidase A precursor gene |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | AcCC1 and AcCC2 are plaque purified occlusion negative recombinant baculovirus resulting from the co-transfection of Sf-9 cells with pCC4 (transfer vector) and AcMNPV DNA. |
| Effect on Host： | Expanded nuclei in enlarged cells (25 - 50% increase in diameter). Lysis at late times p.i |
| Recommended Host： | Sf9 cells (ATCC CRL-1711) many Lepidopterm insect cell lines |
| Growth Conditions： | Temperature: 27°C Incubation: 5-7 days |
| Cryopreservation： | Storage temperature: -70C |
| Name of Depositor： | DH Calhoun |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Nuclear polyhedrosis virus, Autographa californica recombinant with human alpha-galactosidase A precursor gene |
| References： | Calhoun DH, Coppola G. Recombinant alpha-galactosidase A therapy for Fabry disease. US Patent 5,179,023 dated Jan 12 1993 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
Nuclear polyhedrosis virus, Autographa californica
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Nuclear polyhedrosis virus, Autographa californica |
|---|---|
| 商品货号： | TS178084 |
| Classification： | Baculovirus |
| Deposited As： | Nuclear pollyhedrosis virus, Autographa californica (Recombinant) |
| Agent： | Nuclear polyhedrosis virus, Autographa californica |
| Strain： | AcCC1 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Nuclear polyhedrosis virus, Autographa californica recombinant with human alpha-galactosidase A precursor gene |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | AcCC1 and AcCC2 are plaque purified occlusion negative recombinant baculovirus resulting from the co-transfection of Sf-9 cells with pCC4 (transfer vector) and AcMNPV DNA. |
| Effect on Host： | Expanded nuclei in enlarged cells (25 - 50% increase in diameter). Lysis at late times p.i |
| Recommended Host： | Sf9 cells (ATCC CRL-1711) many Lepidopterm insect cell lines |
| Growth Conditions： | Temperature: 27°C Incubation: 5-7 days |
| Cryopreservation： | Storage temperature: -70C |
| Name of Depositor： | DH Calhoun |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Nuclear polyhedrosis virus, Autographa californica recombinant with human alpha-galactosidase A precursor gene |
| References： | Calhoun DH, Coppola G. Recombinant alpha-galactosidase A therapy for Fabry disease. US Patent 5,179,023 dated Jan 12 1993 |
